{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:02:34Z","timestamp":1790337754921,"version":"4.1.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["HA 9566 \/1\\u20131"],"award-info":[{"award-number":["HA 9566 \/1\\u20131"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.mtbio.2026.103539","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T23:45:05Z","timestamp":1786059905000},"page":"103539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["IDH-genotype-linked kinase rewiring accompanies enhanced therapeutic response to dual-drug ferritin nanocages in high-grade glioma"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6319-6895","authenticated-orcid":false,"given":"Mara","family":"Schietinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9942-4580","authenticated-orcid":false,"given":"Sabri E.M.","family":"Sahnoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9020-9353","authenticated-orcid":false,"given":"Edda J.","family":"Krug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3369-2001","authenticated-orcid":false,"given":"Philipp N.","family":"Loewe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8359-9314","authenticated-orcid":false,"given":"Paolo","family":"Alimonti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5771-6278","authenticated-orcid":false,"given":"Emiel P.C.","family":"van der Vorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4579-3996","authenticated-orcid":false,"given":"Najaf","family":"Mammadbayli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5712-6881","authenticated-orcid":false,"given":"Agnieszka","family":"Morgenroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0627-9228","authenticated-orcid":false,"given":"Eva M.","family":"Buhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5059-3965","authenticated-orcid":false,"given":"Alaa A.","family":"Gad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5425-3116","authenticated-orcid":false,"given":"Bernd","family":"Neumaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7212-6521","authenticated-orcid":false,"given":"Felix M.","family":"Mottaghy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8903-0593","authenticated-orcid":false,"given":"J\u00f6rg B.","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4672-5683","authenticated-orcid":false,"given":"Katherine A.","family":"Vallis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5771-216X","authenticated-orcid":false,"given":"Pardes","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mtbio.2026.103539_bib1","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s11060-025-05080-3","article-title":"Survival prediction in glioblastoma: 10-year follow-up from the Dutch neurosurgery quality registry","volume":"174","author":"van Dijck","year":"2025","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.mtbio.2026.103539_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17010146","article-title":"Glioblastoma: clinical presentation, multidisciplinary management, and long-term outcomes","volume":"17","author":"Sipos","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.mtbio.2026.103539_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14102412","article-title":"Epidemiology of glioblastoma multiforme-literature review","volume":"14","author":"Grochans","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.mtbio.2026.103539_bib4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/path.4282","article-title":"Using the molecular classification of glioblastoma to inform personalized treatment","volume":"232","author":"Olar","year":"2014","journal-title":"J. Pathol."},{"key":"10.1016\/j.mtbio.2026.103539_bib5","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.mtbio.2026.103539_bib6","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"360","author":"Yan","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mtbio.2026.103539_bib7","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/s41416-020-0814-x","article-title":"IDH mutation in glioma: molecular mechanisms and potential therapeutic targets","volume":"122","author":"Han","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.mtbio.2026.103539_bib8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11910-023-01265-3","article-title":"Therapies for IDH-mutant gliomas","volume":"23","author":"Alshiekh Nasany","year":"2023","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.mtbio.2026.103539_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010351","article-title":"Molecular mechanisms of treatment resistance in glioblastoma","volume":"22","author":"Ou","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mtbio.2026.103539_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312654","article-title":"Blood-Brain barrier in brain tumors: biology and clinical relevance","volume":"22","author":"Mo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mtbio.2026.103539_bib11","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1158\/1078-0432.CCR-06-2854","article-title":"The blood-brain barrier and cancer: transporters, treatment, and Trojan horses","volume":"13","author":"Deeken","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mtbio.2026.103539_bib12","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","article-title":"An integrative model of cellular states, plasticity, and genetics for glioblastoma","volume":"178","author":"Neftel","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.mtbio.2026.103539_bib13","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12935-024-03331-3","article-title":"New insights into targeted therapy of glioblastoma using smart nanoparticles","volume":"24","author":"Ghaznavi","year":"2024","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.mtbio.2026.103539_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16193300","article-title":"Blood-brain barrier conquest in glioblastoma nanomedicine: strategies, clinical advances, and emerging challenges","volume":"16","author":"Duan","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.mtbio.2026.103539_bib15","doi-asserted-by":"crossref","first-page":"9859","DOI":"10.1007\/s12274-023-5742-7","article-title":"Aptamer-functionalized nanoplatforms overcoming temozolomide resistance in synergistic chemo\/photothermal therapy through alleviating tumor hypoxia","volume":"16","author":"Zeng","year":"2023","journal-title":"Nano Res."},{"key":"10.1016\/j.mtbio.2026.103539_bib16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrn1824","article-title":"Astrocyte-endothelial interactions at the blood-brain barrier","volume":"7","author":"Abbott","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.mtbio.2026.103539_bib17","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/nm.3407","article-title":"Development, maintenance and disruption of the blood-brain barrier","volume":"19","author":"Obermeier","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.mtbio.2026.103539_bib18","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a020412","article-title":"The blood-brain barrier","volume":"7","author":"Daneman","year":"2015","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.mtbio.2026.103539_bib19","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","article-title":"Drug transport across the blood-brain barrier","volume":"32","author":"Pardridge","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.mtbio.2026.103539_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2019.11.009","article-title":"The blood-brain barrier: physiology and strategies for drug delivery","volume":"165-166","author":"Pandit","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.mtbio.2026.103539_bib21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood-brain barrier: bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.mtbio.2026.103539_bib22","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrd.2015.21","article-title":"From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery","volume":"15","author":"Banks","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.mtbio.2026.103539_bib23","doi-asserted-by":"crossref","first-page":"40896","DOI":"10.18632\/oncotarget.5683","article-title":"IDH mutation and MGMT promoter methylation in glioblastoma: results of a prospective registry","volume":"6","author":"Yang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.mtbio.2026.103539_bib24","first-page":"17","article-title":"Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review","volume":"4","author":"Singh","year":"2021","journal-title":"Cancer Drug Resist"},{"key":"10.1016\/j.mtbio.2026.103539_bib25","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/FPC.0b013e32833ffb56","article-title":"Doxorubicin pathways: pharmacodynamics and adverse effects","volume":"21","author":"Thorn","year":"2011","journal-title":"Pharmacogenet. Genom."},{"key":"10.1016\/j.mtbio.2026.103539_bib26","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJM199504133321507","article-title":"Paclitaxel (Taxol)","volume":"332","author":"Rowinsky","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mtbio.2026.103539_bib27","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.canlet.2014.07.018","article-title":"Delivery of doxorubicin across the blood-brain barrier by ondansetron pretreatment: a study in vitro and in vivo","volume":"353","author":"Sardi","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.mtbio.2026.103539_bib28","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1172\/JCI0215451","article-title":"Transport of paclitaxel (taxol) across the blood-brain barrier in vitro and in vivo","volume":"110","author":"Fellner","year":"2002","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.mtbio.2026.103539_bib29","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1038\/s41467-024-48326-w","article-title":"Ultrasound-mediated delivery of doxorubicin to the brain results in immune modulation and improved responses to PD-1 blockade in gliomas","volume":"15","author":"Arrieta","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mtbio.2026.103539_bib30","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s13287-015-0185-z","article-title":"Mesenchymal stromal cells loaded with paclitaxel induce cytotoxic damage in glioblastoma brain xenografts","volume":"6","author":"Pacioni","year":"2015","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.mtbio.2026.103539_bib31","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3892\/etm.2021.9723","article-title":"Analysis of the cytotoxic effects, cellular uptake and cellular distribution of paclitaxel-loaded nanoparticles in glioblastoma cells in vitro","volume":"21","author":"Wang","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.mtbio.2026.103539_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-68017-y","article-title":"Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles","volume":"10","author":"Norouzi","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mtbio.2026.103539_bib33","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.addr.2014.01.008","article-title":"Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system","volume":"72","author":"Aryal","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.mtbio.2026.103539_bib34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jconrel.2010.08.027","article-title":"To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery","volume":"148","author":"Danhier","year":"2010","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2026.103539_bib35","article-title":"Bioengineered ferritin nanocarriers for cancer therapy","volume":"22","author":"Sun","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mtbio.2026.103539_bib36","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jconrel.2019.09.002","article-title":"Ferritin drug carrier (FDC) for tumor targeting therapy","volume":"311-312","author":"He","year":"2019","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2026.103539_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-11220-1","article-title":"Targeting transferrin receptors at the blood-brain barrier improves the uptake of immunoliposomes and subsequent cargo transport into the brain parenchyma","volume":"7","author":"Johnsen","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mtbio.2026.103539_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182954","article-title":"Transferrin receptor-1 and ferritin heavy and light chains in astrocytic brain tumors: expression and prognostic value","volume":"12","author":"Rosager","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.mtbio.2026.103539_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14020279","article-title":"Transferrin receptor-targeted nanocarriers: overcoming barriers to treat glioblastoma","volume":"14","author":"Ramalho","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2026.103539_bib40","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jconrel.2019.12.010","article-title":"Target delivering paclitaxel by ferritin heavy chain nanocages for glioma treatment","volume":"323","author":"Liu","year":"2020","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2026.103539_bib41","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1021\/acsnano.7b06969","article-title":"Ferritin nanocarrier traverses the blood brain barrier and kills glioma","volume":"12","author":"Fan","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2026.103539_bib42","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1002\/bit.28312","article-title":"Simple plant-based production and purification of the assembled human ferritin heavy chain as a nanocarrier for tumor-targeted drug delivery and bioimaging in cancer therapy","volume":"120","author":"Knodler","year":"2023","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.mtbio.2026.103539_bib43","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1158\/0008-5472.CAN-16-2773","article-title":"Chemosensitivity of IDH1-Mutated gliomas due to an impairment in PARP1-Mediated DNA repair","volume":"77","author":"Lu","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.mtbio.2026.103539_bib44","article-title":"Kinome profiling","volume":"2012","author":"Peppelenbosch","year":"2012","journal-title":"Sci. Tech. Rep."},{"key":"10.1016\/j.mtbio.2026.103539_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1012236","article-title":"Novel kinome profiling technology reveals drug treatment is patient and 2D\/3D model dependent in glioblastoma","volume":"12","author":"Fabro","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.mtbio.2026.103539_bib46","doi-asserted-by":"crossref","first-page":"9284","DOI":"10.1038\/s41598-024-60031-8","article-title":"RAPID resistance to BET inhibitors is mediated by FGFR1 in glioblastoma","volume":"14","author":"Jermakowicz","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mtbio.2026.103539_bib47","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1073\/pnas.0408622102","article-title":"Accessing key steps of human tumor progression in vivo by using an avian embryo model","volume":"102","author":"Hagedorn","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mtbio.2026.103539_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.matdes.2024.112715","article-title":"Functional paclitaxel-manganese-doped mesoporous silica nanoparticles for orthotopic brain glioma targeted therapy","volume":"238","author":"Liu","year":"2024","journal-title":"Mater. Des."},{"key":"10.1016\/j.mtbio.2026.103539_bib49","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.3382\/ps\/pew080","article-title":"Effects of breeder age, broiler strain, and eggshell temperature on development and physiological status of embryos and hatchlings","volume":"95","author":"Nangsuay","year":"2016","journal-title":"Poult. Sci."},{"key":"10.1016\/j.mtbio.2026.103539_bib50","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s00109-020-01916-9","article-title":"Microglial-specific depletion of TAK1 is neuroprotective in the acute phase after ischemic stroke","volume":"98","author":"Zeyen","year":"2020","journal-title":"Journal of Molecular Medicine"},{"key":"10.1016\/j.mtbio.2026.103539_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2025.1684982","article-title":"Unbiased kinome profiling identifies key and novel mediators of chronic kidney disease in hyperlipidemic mice","volume":"16","author":"Bonnin-Marquez","year":"2025","journal-title":"Front. Physiol."},{"key":"10.1016\/j.mtbio.2026.103539_bib52","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4939-9036-8_13","article-title":"Profiling activity of cellular kinases in migrating T-Cells","volume":"99-113","author":"Chirumamilla","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.mtbio.2026.103539_bib53","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"10.1016\/j.mtbio.2026.103539_bib68","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jconrel.2018.02.042","article-title":"Ferritin-based drug delivery systems: hybrid nanocarriers for vascular immunotargeting","volume":"282","author":"Khoshnejad","year":"2018","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2026.103539_bib54","doi-asserted-by":"crossref","first-page":"665","DOI":"10.7150\/thno.41692","article-title":"Glioma stem cells and their roles within the hypoxic tumor microenvironment","volume":"11","author":"Boyd","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.mtbio.2026.103539_bib55","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1073\/pnas.0913192107","article-title":"Binding and uptake of H-ferritin are mediated by human transferrin receptor-1","volume":"107","author":"Li","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mtbio.2026.103539_bib56","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/s41467-019-09098-w","article-title":"Cryo-EM structure of the human ferritin-transferrin receptor 1 complex","volume":"10","author":"Montemiglio","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mtbio.2026.103539_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41427-022-00453-w","article-title":"Protein nanoparticle cellular fate and responses in murine macrophages","volume":"15","author":"Ravishankar","year":"2023","journal-title":"NPG Asia Mater."},{"key":"10.1016\/j.mtbio.2026.103539_bib58","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202203102","article-title":"NCOA4 drives ferritin phase separation to facilitate macroferritinophagy and microferritinophagy","volume":"221","author":"Ohshima","year":"2022","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.mtbio.2026.103539_bib59","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ijpharm.2013.06.017","article-title":"Synergistic co-delivery of doxorubicin and paclitaxel using multi-functional micelles for cancer treatment","volume":"454","author":"Duong","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.mtbio.2026.103539_bib60","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.3109\/10717544.2015.1055619","article-title":"Lung cancer combination therapy: co-delivery of paclitaxel and doxorubicin by nanostructured lipid carriers for synergistic effect","volume":"23","author":"Wang","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.mtbio.2026.103539_bib61","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.1046\/j.1432-1327.2000.01606.x","article-title":"Investigation of the alamar blue (Resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity","volume":"267","author":"O'Brien","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.mtbio.2026.103539_bib62","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0022-1759(88)90310-9","article-title":"A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity","volume":"115","author":"Decker","year":"1988","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.mtbio.2026.103539_bib63","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.2016","article-title":"Challenges in exploiting human H ferritin nanoparticles for drug delivery: navigating physiological constraints","volume":"16","author":"Macone","year":"2024","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.mtbio.2026.103539_bib64","doi-asserted-by":"crossref","first-page":"367","DOI":"10.4143\/crt.2020.506","article-title":"Mutant IDH1 enhances temozolomide sensitivity via regulation of the ATM\/CHK2 pathway in Glioma","volume":"53","author":"Lin","year":"2021","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.mtbio.2026.103539_bib65","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000213797","article-title":"Characteristics and outcomes of patients with IDH-Mutant grade 2 and 3 gliomas after deferred or adjuvant radiotherapy","volume":"105","author":"Lanman","year":"2025","journal-title":"Neurology"},{"key":"10.1016\/j.mtbio.2026.103539_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15153838","article-title":"CMGC kinases in health and cancer","volume":"15","author":"Chowdhury","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.mtbio.2026.103539_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2017.05.011","article-title":"AGC kinases, mechanisms of regulation and innovative drug development","volume":"48","author":"Leroux","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.mtbio.2026.103539_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.711088","article-title":"Investigation of the therapeutic effect of doxorubicin combined with focused shockwave on glioblastoma","volume":"11","author":"Liao","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.mtbio.2026.103539_bib70","doi-asserted-by":"crossref","DOI":"10.1007\/s00259-025-07441-6","article-title":"ImmunoPET imaging of c-Met using a nanobody-based tracer [(68)Ga]Ga-NOTA-PFCM01 in pancreatic ductal adenocarcinoma models and non-human primates","author":"Sun","year":"2025","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.mtbio.2026.103539_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29051030","article-title":"Lu-Labeled iron oxide nanoparticles functionalized with doxorubicin and bevacizumab as nanobrachytherapy agents against breast cancer","volume":"29","author":"Salvanou","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.mtbio.2026.103539_bib72","doi-asserted-by":"crossref","first-page":"S208","DOI":"10.1093\/neuonc\/noae125","article-title":"Targeted radionuclide therapy for gliomas: emerging clinical trial landscape","volume":"26","author":"Weller","year":"2024","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.mtbio.2026.103539_bib73","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15010191","article-title":"The CAM Model-Q&A with experts","volume":"15","author":"Fischer","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.mtbio.2026.103539_bib74","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.brainresbull.2022.02.005","article-title":"The chick embryo chorioallantoic membrane as an experimental model to study in vivo angiogenesis in glioblastoma multiforme","volume":"182","author":"Ribatti","year":"2022","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.mtbio.2026.103539_bib75","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s00221-025-07018-7","article-title":"Glioblastoma induced blood-brain barrier dysfunction via a paracrine mechanism that increases claudin-1 expression","volume":"243","author":"Schweiger","year":"2025","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.mtbio.2026.103539_bib76","doi-asserted-by":"crossref","first-page":"29220","DOI":"10.18632\/oncotarget.16352","article-title":"Kinomic profiling identifies focal adhesion kinase 1 as a therapeutic target in advanced clear cell renal cell carcinoma","volume":"8","author":"Ghosh","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.mtbio.2026.103539_bib77","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/neuonc\/not198","article-title":"Increased sensitivity to radiochemotherapy in IDH1 mutant glioblastoma as demonstrated by serial quantitative MR volumetry","volume":"16","author":"Tran","year":"2014","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.mtbio.2026.103539_bib78","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1038\/s41388-017-0077-z","article-title":"Wild-type and mutated IDH1\/2 enzymes and therapy responses","volume":"37","author":"Molenaar","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.mtbio.2026.103539_bib79","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11060-021-03829-0","article-title":"IDH1 mutant glioma is preferentially sensitive to the HDAC inhibitor panobinostat","volume":"154","author":"Sears","year":"2021","journal-title":"J. Neuro Oncol."}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426007842?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426007842?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:24:59Z","timestamp":1790335499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590006426007842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":79,"alternative-id":["S2590006426007842"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103539","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IDH-genotype-linked kinase rewiring accompanies enhanced therapeutic response to dual-drug ferritin nanocages in high-grade glioma","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103539","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103539"}}